FALCONS FORTUNES

Falcons' Fortunes - FACIT's Annual Pitch Competition

Opportunity for Ontario Cancer Researchers to vie for the
"Ernsting Entrepreneurship Award"

Falcons' Fortunes (based on the popular TV series Dragons' Den) invites Ontario-based entrepreneurs working in the oncology space to pitch innovative research ideas to an external panel of judges. Hosted by the FACIT Falcons (i.e. the FACIT team), this annual event offers $50,000 in Prospects funding to invest in the most promising oncology research idea. While the research idea should be novel and sound, the competition is for the best pitch i.e. the presentation that best convinces the investor judging panel on the value of the idea and how $50,000 would improve and/or better illustrate the potential, and if possible commercial, value of the innovative idea itself.

The Falcons’ Fortunes event endeavors to enhance, support and celebrate a culture of commercialization in Ontario, such as the cultivation of skill sets that enable ideas to be successfully pitched to investors and promotion of entrepreneurial spirit.

Eligibility:

The Falcons’ Fortunes pitch competition is open to any Ontario-based entrepreneurial researcher (e.g. academia, research institutions, research hospitals, startups, etc.) working in the oncology space. Joint pitches from up to two researchers are also eligible. Basically, anyone with the entrepreneurial itch should participate!

How to participate:

The next call to participate will be issued in 2020.

Questions?

For more details about the competition, please download the Competition Overview document or contact Lisa Milestone for more information.

Past Winners:

2019: A radially expandable access port to maximize the potential of laparoscopic surgical oncology

Recognizing a real unmet need, Xpan is developing expandable surgical access ports that aim to increase safety and efficiency of minimally invasive surgeries.

 

2019: A radially expandable access port to maximize the potential of laparoscopic surgical oncology2019: A radially expandable access port to maximize the potential of laparoscopic surgical oncology


2018: ReFilx™ – A regenerative filler matrix for breast cancer patients

ReFilx™ is a novel polymeric soft tissue filler that provides breast cancer patients with a cosmetically superior, minimally-invasive and cost-effective solution for the permanent restoration of breast defects following lumpectomy.

2018: ReFilx™ – A regenerative filler matrix for breast cancer patients2018: ReFilx™ – A regenerative filler matrix for breast cancer patients


2017: Development of a Multi-mechanistic Vaccinia Virus-based Platform for the Treatment of Pancreatic Cancer

The novel platform delivers sustained and amplified viral-mediated cell killing specific to pancreatic cancer (PCa) via the production of PCa cell-targeted amiR-containing exosomes.

2017: Development of a Multi-mechanistic Vaccinia Virus-based Platform for the Treatment of Pancreatic Cancer2017: Development of a Multi-mechanistic Vaccinia Virus-based Platform for the Treatment of Pancreatic Cancer


2016: MY-osto-ME

An economical port, bag and belt system for urostomy patients that aims to reduce their rate of complications, facilitate application, and reduce social stigma; overall helping improve the quality of life of bladder cancer patients.

2016: MY-osto-ME2016: MY-osto-ME